Inhibrx Biosciences, Inc. INBX Non-cash lease expense
Non-cash lease expense at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept inbx:NoncashOperatingLeaseExpense.
The official record: Inhibrx Biosciences, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s non-cash lease expense?
- Inhibrx Biosciences, Inc. (INBX) reported non-cash lease expense of $450.75K in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s non-cash lease expense changed year-over-year?
- Inhibrx Biosciences, Inc.'s non-cash lease expense decreased by 5.0% year-over-year, from $474.25K to $450.75K.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s non-cash lease expense?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s non-cash lease expense has grown at a 1.1% compound annual growth rate (CAGR), from $1.77M to $1.8M.
- What does non-cash lease expense mean?
- This represents the non-cash portion of operating lease expenses recognized in the income statement, typically associated with the amortization of right-of-use assets. It is added back to net income in the cash flow statement to reconcile accounting expenses with actual cash outflows. Monitoring this helps investors understand the impact of lease accounting standards on reported profitability without affecting liquidity.